oxazoles has been researched along with fluorouracil in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardalan, B; Chandrasekaran, B; Hrishikeshavan, HJ | 1 |
| Bril, H; Claessen, AM; Meyer, S; Scheper, RJ; Valster, H | 1 |
| Calabresi, P; DiLorenzo, JA; Griswold, DE | 1 |
| Bareham, CR; Calabresi, P; DiLorenzo, JA; Griswold, DE | 1 |
| Kamoi, K; Kawauchi, A; Miki, T; Mizutani, Y; Ukimura, O | 1 |
| Hirakawa, K; Nakazawa, K; Tendo, M; Yamada, N; Yashiro, M | 1 |
| Charpentier, M; Guo, L; Lu, W; Xiao, D; Yan, B; Yang, D | 1 |
7 other study(ies) available for oxazoles and fluorouracil
| Article | Year |
|---|---|
Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemia.
Topics: Animals; Antibiotics, Antineoplastic; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Isoxazoles; Leukemia P388; Leukemia, Experimental; Mice; Oxazoles; Phosphoribosyl Pyrophosphate; Phosphotransferases | 1985 |
Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cyclophosphamide; Dermatitis, Contact; Dose-Response Relationship, Immunologic; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Guinea Pigs; Immunity, Cellular; Infusion Pumps; Oxazoles; Oxazolone | 1989 |
Quantification and pharmacological dissection of oxazolone-induced contact sensitivity in the mouse.
Topics: Animals; Antigens; Cyclophosphamide; Cytarabine; Dermatitis, Contact; Female; Fluorouracil; Immunization; Male; Mice; Mice, Inbred A; Mice, Inbred C3H; Oxazoles; Oxazolone; Plethysmography; Time Factors | 1974 |
Selective alteration of immunocompetence with methotrexate and 5-fluorouracil.
Topics: Animals; Antibody Formation; Antigen-Antibody Complex; Dermatitis, Contact; Female; Fluorouracil; Graft Rejection; Hemolytic Plaque Technique; Hypersensitivity; Immunity, Cellular; Immunoglobulin M; Immunosuppression Therapy; Leucovorin; Male; Methotrexate; Mice; Mice, Inbred Strains; Oxazoles; Serum Albumin, Bovine; Skin Transplantation; Transplantation, Homologous | 1974 |
Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer.
Topics: Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Benzenesulfonates; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Synergism; Fluorouracil; Humans; Isoenzymes; Male; Membrane Proteins; Oxazoles; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2002 |
Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Topics: Adenocarcinoma, Scirrhous; Animals; Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Fibroblasts; Fluorouracil; Hepatocyte Growth Factor; Humans; In Vitro Techniques; Mice; Mice, Nude; Oxazoles; Prostaglandins E; Stomach Neoplasms | 2005 |
Regulation of carboxylesterase-2 expression by p53 family proteins and enhanced anti-cancer activities among 5-fluorouracil, irinotecan and doxazolidine prodrug.
Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Camptothecin; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Line, Tumor; Doxorubicin; Fluorouracil; Gene Expression Regulation, Neoplastic; Hep G2 Cells; HT29 Cells; Humans; Irinotecan; Mice; Oxazoles; RNA Stability; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2013 |